Abstract
A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.
Resumé
L'article présente un cas de rupture de l'utérus provoquée par la PGE2 extraovulaire au cours d'une séquence d'administration intraveineuse d'ocytocine lors d'une interruption de grossesse durant le premier trimestre. Il nous apprend que lorsque l'ocytocine est administrée après les prostaglandines chez des patientes dont l'utérus comporte une cicatrice, il convient d'administrer la dose efficace la plus faible possible.
Resumen
Se presenta un caso de ruptura uterina causada por PGE2 extraovular en una secuencia con oxitocina intravenosa durante la terminación del embarazo en el segundo trimestre. Nos enseña que cuando se utiliza oxitocina después de prostaglandinas en pacientes cuyo útero presenta signos de cicatrización, debe aplicarse la dosis eficaz mínima.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hagay Z, Liberman JR, Picard R, Katz M. Uterine rupture complicating midtrimester abortion —possible preventive measures. J Reprod Med. 1989;34:912–5.
Toppozada M, Ismail AAA. Intrauterne administration of drugs for termination of pregnancy in the second trimester. Bailliere's Clin Obstet Gynecol. 1990;4:327–49.
Cederqvist LL. Prostaglandins, oxytocin and uterine rupture. Lancet. 1983;i:420–1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lurie, S., Hagay, Z. & Borenstein, R. Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy. Adv Contracept 9, 331–333 (1993). https://doi.org/10.1007/BF01983211
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01983211